Promentis Pharmaceuticals

About:

Promentis Pharmaceuticals focuses on developing antipsychotic drugs to treat schizophrenia.

Website: http://www.promentispharma.com

Top Investors: OrbiMed, F-Prime Capital, National Institutes of Health, Aisling Capital, Golden Angels Investors

Description:

Promentis Pharmaceuticals discovers, develops, and markets new drugs for the treatment of important human diseases, focusing initially on developing a new antipsychotic drug to treat schizophrenia. Promentis Pharmaceuticals was founded in 2006 and is based in Milwaukee, Wisconsin.